Sanofi Will Maintain “Massive” Investment Behind Ambien CR
This article was originally published in The Pink Sheet Daily
Executive Summary
Company will continue to invest in sales reps, DTC ads for sleep aid in line with competitors' spending.
You may also be interested in...
Generic Ambien To Launch Immediately Following FDA Approval
FDA approves the first generic versions of Sanofi-Aventis’ immediate-release zolpidem.
Sanofi-Aventis Ambien CR Launch Gets Up And Going
Sleep aid introduction is being promoted with 3,500 sales reps, DTC ads breaking mid-November.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.